U.S. Scientists Wary Of Traveling To China

This summer, three years after the prodemocracy demonstrations in Tiananmen Square and the subsequent Chinese government crackdown on participants—including many scientists and students—at least two important scientific meetings, one in entomology and one in physics, have been scheduled in Beijing. Because of China's record of human rights abuses, the original siting of the meetings in China has been hotly debated within each scientific community, with some concerned United States

Written byFranklin Hoke
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

This summer, three years after the prodemocracy demonstrations in Tiananmen Square and the subsequent Chinese government crackdown on participants—including many scientists and students—at least two important scientific meetings, one in entomology and one in physics, have been scheduled in Beijing. Because of China's record of human rights abuses, the original siting of the meetings in China has been hotly debated within each scientific community, with some concerned United States scientists in favor of boycotting the gatherings to protest the current regime. These scientists as well as others who have yet to decide whether they will attend the sessions are also trying to judge who will be helped or hurt by refusing to attend the Chinese meetings—and whether such refusal might, in fact, redound to the detriment of the boycotters. "As scientists, we all have a special obligation to protect freedom of expression, in the same way that attorneys have a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies